Patient-derived lymphoma spheroids reveal predictive markers of glofitamab resistance in relapsed/refractory B-NHL.

Marcoux P, Gava F, Tosolini M, Gravelle P, Schniederjohann C, Quertinmont S, Serrat N, Bouquet F, Herter S, Tarte K, Roussel M, Sesques P, Bret C, Rossi C, Aubert P, Morschhauser F, Cartron G, Huber W, Dietrich S, Ysebaert L, Brousset P, Bruch PM, Pérez-Galán P, Bezombes C, Laurent C

Open source

DOI: 10.1182/blood.2025031309
Published: 2026 Jun 4
Container: Blood
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2025031309,
  title = {Patient-derived lymphoma spheroids reveal predictive markers of glofitamab resistance in relapsed/refractory B-NHL.},
  author = {Marcoux P and Gava F and Tosolini M and Gravelle P and Schniederjohann C and Quertinmont S and Serrat N and Bouquet F and Herter S and Tarte K and Roussel M and Sesques P and Bret C and Rossi C and Aubert P and Morschhauser F and Cartron G and Huber W and Dietrich S and Ysebaert L and Brousset P and Bruch PM and Pérez-Galán P and Bezombes C and Laurent C},
  year = {2026},
  journal = {Blood},
  doi = {10.1182/blood.2025031309},
  url = {https://doi.org/10.1182/blood.2025031309}
}

RIS

TY  - JOUR
TI  - Patient-derived lymphoma spheroids reveal predictive markers of glofitamab resistance in relapsed/refractory B-NHL.
AU  - Marcoux P
AU  - Gava F
AU  - Tosolini M
AU  - Gravelle P
AU  - Schniederjohann C
AU  - Quertinmont S
AU  - Serrat N
AU  - Bouquet F
AU  - Herter S
AU  - Tarte K
AU  - Roussel M
AU  - Sesques P
AU  - Bret C
AU  - Rossi C
AU  - Aubert P
AU  - Morschhauser F
AU  - Cartron G
AU  - Huber W
AU  - Dietrich S
AU  - Ysebaert L
AU  - Brousset P
AU  - Bruch PM
AU  - Pérez-Galán P
AU  - Bezombes C
AU  - Laurent C
PY  - 2026
JO  - Blood
DO  - 10.1182/blood.2025031309
UR  - https://doi.org/10.1182/blood.2025031309
ER  -

APA

P, M., F, G., M, T., P, G., C, S., S, Q., N, S., F, B., S, H., K, T., M, R., P, S., C, B., C, R., P, A., F, M., G, C., W, H., S, D., L, Y., P, B., PM, B., P, P., C, B., & C, L. (2026). Patient-derived lymphoma spheroids reveal predictive markers of glofitamab resistance in relapsed/refractory B-NHL.. Blood. https://doi.org/10.1182/blood.2025031309

Source records

pubmed · retrieved 2026-09-27T07:50:59.514Z